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*e pepper tree Schinus molle L. is an evergreen ornamental plant belonging to the Anacardiaceae family, native to South
America and widespread throughout the world. It has biological activities and is used in folk medicine. *is paper aims to
contribute to a deeper knowledge of its chemical composition and biological properties. S. molle leaf extracts were obtained
by sequential extraction with solvents of different polarities and subsequently tested on the HL-60 human leukaemia cell
line to define a possible cytotoxic activity. Among the investigated extracts, the petroleum ether extract revealed a high
cytotoxic activity, and its chemical composition was further investigated. By a silica column chromatography, eight
fractions were obtained, and their compositions were determined by GC-MS analysis. Compounds and relative abundance
differed widely among the fractions; sesquiterpenes resulted the main component and alcoholic sesquiterpenes the
most abundant.
1. Introduction
“Pink pepper” is the common name of Schinus molle L., a
plant belonging to the Anacardiaceae family, which
originates in South America and nowadays distributed
throughout the world [1, 2]. S. molle is a dioecious plant
with a peppery smell lanceolate leaves, pendulous branches
with yellowish-white flowers arranged in clusters, and
coral-red fruits in the size of peppercorns [3]. Some studies
investigated different parts of the plant such as leaves,
mature as well as immature fruits, stems, and branches to
define the molecular composition and the related bi-
ological activities [4–8]. S. molle leaf essential oils showed
antibacterial and antifungal activities [9–12], and anti-
cancer and anti-inflammatory properties were also re-
ported [13–16].
In view of the growing interest in the application of the
natural products in the food and pharmaceuticals and in
order to contribute for a deeper knowledge of biological
properties of S. molle, we report here our findings con-
cerning the molecules possibly involved in the cytotoxic
activity.
2. Materials and Methods
2.1. Plant Collection and Extract Preparation. Fresh leaves of
female S. molle (SML) plant were collected at “Angelo
Rambelli” Botanical Garden (Tuscia University, Viterbo,
Italy) in October 2017, out of the flowering period.*e plant
materials were washed with distilled water, air-dried in a
shaded area for 2–4 days, and carefully hand-selected to
separate the leaves, which were kept in a plastic container
and frozen at −80°C for freeze-drying. After lyophilisation,
the dried material was chopped and stored at 4°C until use.
Dried leaves (3.5 g) were extracted using three solvents
(100mL each) of increasing polarity such as petroleum ether,
diethyl ether, and acetone in a Soxhlet apparatus. After 6
extraction cycles for each solvent (SML1: petroleum ether
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extract; SML2: diethyl ether extract; SML3: acetone extract),
the solid extracts were obtained by rotary evaporation (RV
08-VC, IKA, USA) at low pressure and 40°C of temperature.
*e yield percentage from the dried extracts was cal-
culated using the following equation:
yield percentage �
(W1∗ 100)
W2
, (1)
where W1 is the dry weight of the extract after evaporating
the solvent and W2 is the weight of the dried leaves.
2.2. Cell Line and Culture Conditions. *e human pro-
myelocytic leukaemia cell line (HL-60) was purchased from
American Type Culture Collection (ATCC). *is cell line
was cultured in RPMI 1640 containing 1mmol/L L-gluta-
mine, supplemented with 10% (v/v) fetal bovine serum
(FBS) and 1% (w/v) penicillin/streptomycin, andmaintained
at 37°C in humidified 5%CO2 incubator.*ree times a week,
cells were diluted to maintain a density of 5×105/mL and
harvested in the exponential phase of growth.
2.3. Cell Viability Assay. To analyse the cell viability, MTT
assay was used. *is is a colorimetric assay able to measure
the reduction of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-
2H-tetrazolium bromide (MTT) by mitochondrial succinate
dehydrogenase. MTT enters the cells and passes into the
mitochondria where it is reduced to an insoluble, coloured,
formazan product. *e formazan crystals inside the cells are
then solubilised with an organic solvent (DMSO) and the
released, solubilised reagent is measured spectrophoto-
metrically [17]. HL-60 cells were seeded in flat-bottom 96-
well plates at a density of 1× 104 cells/well and treated with
ten 2-fold dilutions (250 μg/ml–0.485 μg/ml) for 24 h. As
negative control, untreated cells were added. Vinblastine
(V1377, Merck, Germany) was used as positive control with
eleven 2-fold dilutions (10−6M to 10−9M) for 24 h. For
solvent control, cells were treated with 0.1% DMSO for 24 h.
Following treatment incubation time, the media was
carefully aspirated and 100 μL of MTTsolution (0.5mg/mL)
added to each well; after 3 h of incubation at 37°C, the
formazan crystals were dissolved with 100 μL of DMSO.
Plates were read by a Sunrise Tecan microplate reader, and
the absorbance was measured at 595 nm. *e amount of
colour produced is directly proportional to the number of
viable cells.
Data showed in the present paper represented the av-
erage values of three independent measurements. EC50 value
(effective concentration value) was defined as the concen-
tration of treatment at which there was 50% growth in-
hibition of cell proliferation.
2.4. Low-Pressure Column Chromatography. SML1 (0.296 g)
was fractionated by low-pressure column chromatography
(LPLC) using silica gel 60H (0.04–0.063mm) (Macherey-
Nagel, Germany) as stationary phase [18]. *e silica powder
was added in a beaker to the mobile phase solvents used
(hexane/diethyl ether, 80/20) and stirred to obtain a
pourable slurry.
*e stationary phase was packed into a glass column
(h� 25 cm; d� 2.5 cm). A layer of sand was placed at the top
of the silica gel, and the sample was dissolved in a small
amount of the initial mobile phase and gently applied to the
top of the column bed. Mixtures (v/v) of hexane (HX),
diethyl ether (DE), ethyl acetate (EA), and ethanol (EtOH) in
increased polarity mode were used for the elution (HX/DE
80/20; HX/DE 70/30; HX/DE 65/35; HX/DE 60/40; HX/DE
50/50; HX/DE 40/60; DE 100; DE/EA 90/10; DE/EA 80/20;
DE/EA 50/50; EA 100; EA/EtOH 50/50), and the mobile
phase was dropped under gravity. Fractions were collected
manually, and the yield percentage of each fraction was
calculated considering the dry weight of fraction after
evaporating the solvent and weight of SML1.
2.5. 0in-Layer Chromatography. Fractions obtained by
LPLC were analysed by thin-layer chromatography (TLC)
with the purpose of defining the ones with similar chro-
matographic profiles and to group them. Precoated TLC
sheets (20× 20 cm Alugram® Xtra SIL G/UV254 sheetplates, Macherey-Nagel, Germany) were used for TLC.
Samples were spotted on the bottom of the plate (approx-
imately 1.5 cm above edge) by a Hamilton microsyringe.
Afterwards, the TLC plates were placed in a presaturated
chamber with solvents mixture HX/DE (80/20) and were let
to develop. *e plates were removed from the chamber
before the solvents mixture reached their tops and allowed to
dry under the hood and the separated spots were inspected
by UV lights (254 nm and 365 nm, respectively). For ter-
penoid compounds detection, TLC plates were sprayed with
vanillin/sulphuric acid (4.0%) and the fractions with a
similar chromatographic profile were combined.
2.6. GC-MS Analysis. *e GC-MS analyses (two repetitions
for each sample) were performed using a PerkinElmer gas
chromatograph, Model Clarus 500, equipped with a polar
capillary column (Restek Stabilwax fused silica) directly
coupled to a mass selective detector of the same company
operated in the EI mode (70 eV).
Helium was used as the carrier gas at a flow rate of
1mLmin−1. *e operating conditions were as follows: in-
jector temperature 250°C and the oven temperature pro-
gram: isothermal at 60°C for 5min, ramped to 220°C at a rate
of 5°Cmin−1, and finally isothermal at 220°C for 15min. *e
dried extract and each fraction were dissolved in 1ml of
methanol and the injection volume for all samples was 2 μL.
*e injector split ratio was 1 :10. *e extract constituents
were identified by comparison of their linear retention in-
dices (relative to C8–C30 aliphatic hydrocarbons, Ultrasci
injected directly into GC injector under the same operating
conditions reported above) with literature values and their
mass spectra were compared with those from Wiley and
NIST libraries. GC-FID analysis was performed under the
same experimental conditions using the same column as
described for the GC-MS measurements. *e FID tem-
perature was 280°C. Percentage area values were obtained
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electronically from the GC-FID response, without the use of
an internal standard or correction factors.
2.7. Statistical Analysis. *e EC50 values from three in-
dependent graphic plots of the dose-response curve were
expressed as means± standard error of the mean (SEM).
Statistical analysis was performed by one-way analysis of
variance (ANOVA test) using a Stat-Plus software (Analy-
stSoft VC 2009) with the threshold of significance set at
p< 0.05.
3. Results and Discussion
3.1. S. molle Extract Yields and Its Antiproliferative Activity.
*e yields of the three extracts obtained from S. molle leaves
are reported in Table 1. Petroleum ether extract (SML1)
showed a yield about 8%, while the diethyl ether extract
(SML2) and acetone extract (SML3) had a minor yield (1.4%
and 2.0%, respectively). SML1, SML2, and SML3 were in-
vestigated by MTT assay to define the antiproliferative ac-
tivities on human leukaemia cells (HL-60 cells). Each sample
showed dose-dependent inhibition effects after 24 h of
treatment. EC50 of the extracts exhibited values not ex-
ceeding 30.0 μg/mL. *e petroleum ether extract (SML1)
showed a stronger antiproliferative activity with an EC50
value of 13.3± 6.1 μg/mL (Table 1).
3.2. LPLC Fractions. According to the results obtained by
MTT assay, SML1 was fractionated by LPLC to investigate
its components, and after comparison by TLC, those
having a similar chromatographic profile were reunited in
eight final fractions (F1–F8) whose yields are reported in
Table 2.
3.3. GC-MS Analyses. SML1 was analysed by GC and GC-
MS analytical techniques, revealing that the extract consisted
of 31 components (Table 3). *e composition of the extract
was dominated by sesquiterpene alcohol (56.41%), sesqui-
terpene hydrocarbons (25.17%), and a lower percentage of
monoterpene hydrocarbons (4.18%). *e major identified
component from the sesquiterpenes family was elemol
(46.28%) followed by germacrene D (18.10%); on the con-
trary, sabinene was detected as the major constituent of the
terpenes group (1.65%). *e presence of the squalene was
relevant reaching 10.60%. Deveci et al. [19] reported ger-
macrene D as a major constituent of S. molle leaf hexane
extract. *e composition of Schinus may differ by seasons,
regions from which the plant material was collected, and by
solvents and parts (leaves or fruits) of the plant used for the
extraction [20].
*e GC-MS analysis of the fractions obtained from the
extract consisted of a mixture of different classes of
identified compounds, which are reported as separate
columns in Table 3. *e main components of fraction F1
were δ-cadinene (50.58%), germacrene D (20.70%), and
dehydroxy-isocalamendiol (18.45%). Fraction F2 was
mainly characterised by elemene (72.16%) whereas
dehydroxy-isocalamendiol (73.85%) was the most abun-
dant in fraction F3. Fraction F4 was almost constituted by
squalene (93.85%) while fraction F5 was made up of two
components: β-thujene (49.88%) and β-terpinene (50.12%),
present in similar percentage ratio. In fraction F6, β-thujene
was the main component (67.97%) followed by sabinene
(23.37%). Fraction F7 was almost entirely constituted by
alloaromadendrene (95.21%) while the fraction F8 by
β-eudesmol (65.87%). Other works reported the identifi-
cation of high amounts of sesquiterpenes in the analysed
extracts [21].
3.4. Antiproliferative Activity of LPLC Fractions. *e frac-
tions obtained by LPLC were tested by MTT and the results
are reported in Table 2. Each of the eight fractions showed a
relevant antiproliferative activity against human leukaemia
cells with EC50 values ranging from 143.5 μg/mL to 3.8 μg/mL.
Fraction F4, in which squalene represents 93.85%, was found
to be the most active (EC50: 3.8μg/mL). Squalene is a tri-
terpene molecule able to inhibit chemically induced colon,
lung, and skin tumorigenesis in rodents and is investigated as
an adjuvant cancer therapy [22–26].
Fractions F5 and F6, with a similar antiproliferative
activity (EC50: 4.1 μg/mL; 5.4 μg/mL respectively), were
mainly characterised by components belonging to the family
of terpenes (β-thujene, β-terpinene, and sabinene). In
particular, β-thujene from several plants and/or essential oils
[27] has been described to be important for its antioxidant
and antimicrobial activities.
β-Terpinene is one of three isomeric monoterpenes
differing in the positions of their two double bonds (α- and
c-terpinene being the others). Terpinenes are three isomeric
hydrocarbons that are classified as terpenes. Terpenes, one of
the most extensive and varied structural group of com-
pounds occurring in nature, display a wide range of
Table 1: Obtained yields and antiproliferative activities of S. molle
leaf extracts (SML1, SML2, and SML3) against human leukaemia
cells (HL-60) expressed by EC50 (mean values± SEM).
Extracts Yields (%) EC50 (μg/mL)
SML1 8.4 13.3± 6.1
SML2 1.4 23.8± 3.8
SML3 2.0 27.4± 7.0
Table 2: SML1 fractions obtained by LPLC and tested on human
leukaemia cells (HL-60).
LPLC fractions Yields (%) EC50 (μg/mL)
F1 23.7 6.5± 0.9
F2 30.3 12.8± 1.3
F3 3.6 5.5± 0.4
F4 1.9 3.8± 0.3
F5 1.7 5.4± 0.3
F6 4.7 4.1± 0.3
F7 11.4 143.5± 34.1
F8 4.6 37.9± 10.7
Cytotoxic activity was expressed by EC50 (mean values± SEM). Vinblastine
was used as positive control (EC50 �12.2± 1.3 nM).
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biological and pharmacological activities and strong anti-
oxidant property [28]. Wiart [29] has reported that the
terpenes compromise the cell cycle in different types of
malignancies by targeting the mitotic spindle and cyclins
and thus triggering apoptosis.
Fractions F3 and F5 (EC50: 5.5 μg/mL; 6.5 μg/mL, re-
spectively) are characterised by the presence of compounds
belonging to the sesquiterpenes group. Dehydroxy-iso-
calamendiol is the main component of fraction F3 (73.85%)
and is also present in fraction F1 (18.45%). *is compound
has been reported in essential oil from leaves and fruits of
S. molle grown in Saudi Arabia [30].
In fraction F1, germacrene D was present; it is known
that germacrene D has strong antimicrobial activity [31], and
de Oliveira et al. [32] found some oils having anticancer
effects in various cancer cell lines, with germacrene D as one
of the main compounds.
4. Conclusions
In our study, the chemical composition of the petroleum
ether extract (SML1) from leaves of Schinus molle L. and its
eight fractions were determined by GC-MS and tested on
HL-60 human leukaemia cells. *e major component of the
extract was elemol followed by germacrene D and squalene.
*e obtained fractions were abundantly rich in secondary
metabolites such as monoterpenes and sesquiterpenes. *e
MTT results of the fractions demonstrated a relevant anti-
proliferative activity against human leukaemia cells. Con-
sidering both biological and chemical results, we hypothesise
that the presence of compounds belonging to the family of
terpenes (monoterpenes and sesquiterpenes) could be re-
sponsible for the activity against human leukaemia cells
(HL-60). In the next future, the molecules here identified as
possible responsible for anticancer activity could open
Table 3: Chemical composition (%) of the petroleum ether extract (SML1) and fractions from female S. molle leaves.
Component LRI1 LRI2 SML1∗ F1 F2 F3 F4 F5 F6 F7 F8
Sabinene 1112 1107 1.63 — 1.45 6.35 2.65 — 23.37 — —
β-*ujene 1122 1117 0.72 — 1.04 4.45 2.46 49.88 67.97 — —
(+)-4-Carene 1153 1149 0.43 — — 0.92 0.56 — 8.66 — 2.15
α-Phellandrene 1168 1160 0.34 — — — — — — — —
β-Terpinene 1210 1206 0.68 — — — — 50.12 — 4.79 7.63
c-Terpinene 1251 1244 0.20 — — 3.35 0.48 — — — —
Terpinolene 1296 1290 0.18 — — 5.97 — — — — —
α-Copaene 1491 1487 0.37 — — — — — — — —
α-Gurjunene 1532 1527 0.75 — — — — — — — —
β-Ylangene 1580 1574 0.36 — — — — — — — —
β-Elemene 1590 1583 1.40 1.78 — — — — — — —
β-Caryophyllene 1624 1619 2.22 3.40 — — — — — — —
c-Elemene 1649 1641 1.10 0.94 — — — — — — —
Alloaromadendrene 1655 1649 0.31 — — 5.11 — — — 95.21 —
α-Humulene 1672 1667 0.85 1.46 — — — — — — —
c-Muurolene 1682 1676 0.21 1.42 — — — — — — —
Germacrene D 1720 1717 18.10 20.70 — — — — — — —
δ-Cadinene 1761 1758 1.60 50.58 — — — — — — —
c-Cadinene 1768 1760 0.12 1.27 — — — — — — —
Bicyclogermacrene 1773 1769 0.40 — — — — — — — —
Palustrol 1942 1936 0.46 — — — — — — — —
Germacrene D-4-ol 2062 2058 2.40 — 3.47 — — — — — —
Elemol 2079 2076 46.28 — 72.16 — — — — — —
Viridiflorol 2093 2091 1.18 — 6.01 — — — — — —
Dehydroxy-isocalamendiol 2138 — 1.41 18.45 — 73.85 — — — — —
Spathulenol 2140 2136 0.35 — 0.45 — — — — — —
c-Eudesmol 2184 2176 0.68 — 2.70 — — — — — 24.35
α-Eudesmol 2240 2232 1.69 — 6.06 — — — — — —
β-Eudesmol 2255 2249 1.96 — 6.66 — — — — — 65.87
Squalene 2853 2865+ 10.60 — — — 93.85 — — — —
Total 98.98 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Monoterpene hydrocarbons 4.18 — 2.49 21.04 6.16 100.00 100.00 4.79 9.78
Sesquiterpene hydrocarbons 25.17 78.15 — 5.11 — — — 95.21 90.22
Sesquiterpene alcohol 56.41 18.45 97.51 79.85 — — — — —
Bicyclic sesquiterpenes 2.62 3.40 — — — — — — —
Triterpenes 10.60 — — — 93.85 — — — —
1Linear retention indices measured on polar column; 2linear retention indices from the literature; +normal alkane RI; ∗female petroleum ether extract; F1 to
F8: fractions from the petroleum extract; —, not available.
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perspectives to formulate new chemotherapeutic agents of
natural origin.
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